{"nct_id":"NCT03126110","title":"Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2017-04-25","start_date_type":"ACTUAL","primary_completion_date":"2021-11-09","primary_completion_date_type":"ACTUAL","completion_date":"2021-11-09","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["INCY"]}